Kara-Louise Royle

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Multiple Myeloma

Top Venues

Diagnostic and prognostic research

Health technology assessment (Winchester, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Fiona J Collinson, Kara-Louise Royle, Jayne Swain, Christy Ralph, Anthony Maraveyas, Tim Eisen, Paul D Nathan, Robert J Jones, David M Meads, Tze Min Wah, Adam Martin, Janine Bestall, Christian Kelly-Morland, Christopher Linsley, Jamie B Oughton, Kevin Chan, Elisavet Theodoulou, Gustavo A Arias-Pinilla, Amy Kwan, Luis Daverede, Catherine Handforth, Sebastian Trainor, Abdulazeez Salawu, Christopher McCabe, Vicky J Goh, David L Buckley, Jenny Hewison, Walter Martin Gregory, Peter John Selby, Julia M Brown, Janet E Brown, null null
Temporary treatment cessation compared with continuation of tyrosine kinase inhibitors for adults with renal cancer: the STAR non-inferiority RCT. Health technology assessment (Winchester, England) 28 (45) (2024)
Kara-Louise Royle, David Meads, Jennifer K Visser-Rogers, Ian R White, David A Cairns
How is overall survival assessed in randomised clinical trials in cancer and are subsequent treatment lines considered? A systematic review. Trials 24 (1) (2023)
Kara-Louise Royle, Amy Beth Coulson, Karthik Ramasamy, David A Cairns, Anna Hockaday, Sergio Quezada, Mark Drayson, Martin Kaiser, Roger Owen, Holger W Auner, Gordon Cook, David Meads, Catherine Olivier, Lorna Barnard, Rhiannon Lambkin, Andrea Paterson, Bryony Dawkins, Mike Chapman, Guy Pratt, Rakesh Popat, Graham Jackson, Ceri Bygrave, Jonathan Sive, Ruth de Tute, Andrew Chantry, Christopher Parrish, Mark Cook, Samir Asher, Kwee Yong
Risk and response adapted therapy following autologous stem cell transplant in patients with newly diagnosed multiple myeloma (RADAR (UK-MRA Myeloma XV Trial): study protocol for a phase II/III randomised controlled trial. BMJ open 12 (11) (2022)
Amy Beth Coulson, Kara-Louise Royle, Charlotte Pawlyn, David A Cairns, Anna Hockaday, Jennifer Bird, Stella Bowcock, Martin Kaiser, Ruth de Tute, Neil Rabin, Kevin Boyd, John Jones, Christopher Parrish, Hayley Gardner, David Meads, Bryony Dawkins, Catherine Olivier, Rowena Henderson, Phillip Best, Roger Owen, Matthew Jenner, Bhuvan Kishore, Mark Drayson, Graham Jackson, Gordon Cook
F railty-adjusted therapy i n T ransplant N on- E ligible patient s with newly diagno s ed Multiple Myeloma (FiTNEss (UK-MRA Myeloma XIV Trial)): a study protocol for a randomised phase III trial. BMJ open 12 (6) (2022)
Kara-Louise Royle, David A Cairns
The development and validation of prognostic models for overall survival in the presence of missing data in the training dataset: a strategy with a detailed example. Diagnostic and prognostic research 5 (1) (2021)